Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206843 · ClinicalTrials.gov registry record · NA
Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)
A NA study, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- NA
- Development phase
- 630
- Enrollment target
NCT00206843 is a NA study that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 630 participants.
The verdict
NCT00206843, a NA study, has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- NA
- Development phase
- 630 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether physicians can make more informed treatment, admission, and discharge decisions related to patient care by having serial Triage® BNP test results available to assess disease severity, while patients are being treated for HF in the Emergency Department and/or during their admission. This is believed to lead to a better outcome as well as more efficient and cost-effective treatment.
Interventions
- DEVICE Triage BNP Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00206843
The ClinicalTrials.gov registry entry for NCT00206843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 630 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triage BNP Test is the first listed.
NCT00206843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00206843 about?
NCT00206843 is a clinical study titled "Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)". The purpose of this study is to test whether physicians can make more informed treatment, admission, and discharge decisions related to patient care by having serial Triage® BNP test results available to assess disease severity, while patients are being treated for HF in the Emergency Department and...
What is the current status of trial NCT00206843?
This trial is currently completed. It is a NA study. The enrollment target is 630 participants. The study started on 2004-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00206843?
The interventions under investigation include: Triage BNP Test (DEVICE).
Who is sponsoring clinical trial NCT00206843?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.